Literature DB >> 25410026

Revealing the potential pathogenesis of glioma by utilizing a glioma associated protein-protein interaction network.

Weiran Pan1, Gang Li, Xiaoxiao Yang, Jinming Miao.   

Abstract

This study aims to explore the potential mechanism of glioma through bioinformatic approaches. The gene expression profile (GSE4290) of glioma tumor and non-tumor samples was downloaded from Gene Expression Omnibus database. A total of 180 samples were available, including 23 non-tumor and 157 tumor samples. Then the raw data were preprocessed using robust multiarray analysis, and 8,890 differentially expressed genes (DEGs) were identified by using t-test (false discovery rate < 0.0005). Furthermore, 16 known glioma related genes were abstracted from Genetic Association Database. After mapping 8,890 DEGs and 16 known glioma related genes to Human Protein Reference Database, a glioma associated protein-protein interaction network (GAPN) was constructed. In addition, 51 sub-networks in GAPN were screened out through Molecular Complex Detection (score ≥ 1), and sub-network 1 was found to have the closest interaction (score = 3). What' more, for the top 10 sub-networks, Gene Ontology (GO) enrichment analysis (p value < 0.05) was performed, and DEGs involved in sub-network 1 and 2, such as BRMS1L and CCNA1, were predicted to regulate cell growth, cell cycle, and DNA replication via interacting with known glioma related genes. Finally, the overlaps of DEGs and human essential, housekeeping, tissue-specific genes were calculated (p value = 1.0, 1.0, and 0.00014, respectively) and visualized by Venn Diagram package in R. About 61% of human tissue-specific genes were DEGs as well. This research shed new light on the pathogenesis of glioma based on DEGs and GAPN, and our findings might provide potential targets for clinical glioma treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25410026     DOI: 10.1007/s12253-014-9848-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  36 in total

Review 1.  Changed relative to what? Housekeeping genes and normalization strategies in human brain gene expression studies.

Authors:  Elizabeth M Tunbridge; Sharon L Eastwood; Paul J Harrison
Journal:  Biol Psychiatry       Date:  2010-07-31       Impact factor: 13.382

2.  Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

Authors:  Jörg van den Boom; Marietta Wolter; Rork Kuick; David E Misek; Andrew S Youkilis; Daniel S Wechsler; Clemens Sommer; Guido Reifenberger; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

3.  Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex.

Authors:  Anatoly Y Nikolaev; Nikolaos A Papanikolaou; Muyang Li; Jun Qin; Wei Gu
Journal:  Biochem Biophys Res Commun       Date:  2004-10-29       Impact factor: 3.575

Review 4.  Understanding high grade glioma: molecular mechanism, therapy and comprehensive management.

Authors:  Yongzhi Wang; Tao Jiang
Journal:  Cancer Lett       Date:  2013-01-20       Impact factor: 8.679

Review 5.  Mitogenic signaling cascades in glial tumors.

Authors:  Gurpreet S Kapoor; Donald M O'Rourke
Journal:  Neurosurgery       Date:  2003-06       Impact factor: 4.654

6.  Development of human protein reference database as an initial platform for approaching systems biology in humans.

Authors:  Suraj Peri; J Daniel Navarro; Ramars Amanchy; Troels Z Kristiansen; Chandra Kiran Jonnalagadda; Vineeth Surendranath; Vidya Niranjan; Babylakshmi Muthusamy; T K B Gandhi; Mads Gronborg; Nieves Ibarrola; Nandan Deshpande; K Shanker; H N Shivashankar; B P Rashmi; M A Ramya; Zhixing Zhao; K N Chandrika; N Padma; H C Harsha; A J Yatish; M P Kavitha; Minal Menezes; Dipanwita Roy Choudhury; Shubha Suresh; Neelanjana Ghosh; R Saravana; Sreenath Chandran; Subhalakshmi Krishna; Mary Joy; Sanjeev K Anand; V Madavan; Ansamma Joseph; Guang W Wong; William P Schiemann; Stefan N Constantinescu; Lily Huang; Roya Khosravi-Far; Hanno Steen; Muneesh Tewari; Saghi Ghaffari; Gerard C Blobe; Chi V Dang; Joe G N Garcia; Jonathan Pevsner; Ole N Jensen; Peter Roepstorff; Krishna S Deshpande; Arul M Chinnaiyan; Ada Hamosh; Aravinda Chakravarti; Akhilesh Pandey
Journal:  Genome Res       Date:  2003-10       Impact factor: 9.043

7.  Length bias correction in gene ontology enrichment analysis using logistic regression.

Authors:  Gu Mi; Yanming Di; Sarah Emerson; Jason S Cumbie; Jeff H Chang
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

8.  The implications of relationships between human diseases and metabolic subpathways.

Authors:  Xia Li; Chunquan Li; Desi Shang; Jing Li; Junwei Han; Yingbo Miao; Yan Wang; Qianghu Wang; Wei Li; Chao Wu; Yunpeng Zhang; Xiang Li; Qianlan Yao
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

9.  Decreased expression of LATS1 is correlated with the progression and prognosis of glioma.

Authors:  Tianhai Ji; Dan Liu; Wei Shao; Wensheng Yang; Haiqiao Wu; Xiuwu Bian
Journal:  J Exp Clin Cancer Res       Date:  2012-08-21

10.  BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells.

Authors:  Pengjin Mei; Jin Bai; Meilin Shi; Qinghua Liu; Zhonglin Li; Yuechao Fan; Junnian Zheng
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more
  3 in total

1.  A Network Biology Approach to Decipher Stress Response in Bacteria Using Escherichia coli As a Model.

Authors:  Shashwat Deepali Nagar; Bhavye Aggarwal; Shikha Joon; Rakesh Bhatnagar; Sonika Bhatnagar
Journal:  OMICS       Date:  2016-05

2.  LINC01198 facilitates gliomagenesis through activating PI3K/AKT pathway.

Authors:  Yuan Xie; Yuan Cheng
Journal:  RNA Biol       Date:  2020-05-07       Impact factor: 4.652

3.  LncRNA FOXD3-AS1 Promotes Tumorigenesis of Glioma via Targeting miR-128-3p/SZRD1 Axis.

Authors:  Zhang Li; Ming Li; Pengcheng Xia; Lili Wang; Zhiming Lu
Journal:  Cancer Manag Res       Date:  2021-12-07       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.